Concepedia

Loral E. Showalter

LE

Statistics

Publications

5

Citations

83

H-Index

5

Active since

2017

Affiliations

Kent State University(Current)

Moffitt Cancer Center

Loral E. Showalter is an author at Kent State University specializing in pharmacology, cancer immunotherapy, and cancer vaccines.

ORCID

Publications per year

2017–2020

5

Publications

5

Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib

Loral E. Showalter, Crystal M. Oechsle, Nirmala Ghimirey et al. · PLoS ONE · 2019 · 22 citations · Full text

, , +17

Statin Drugs Plus Th1 Cytokines Potentiate Apoptosis and Ras Delocalization in Human Breast Cancer Lines and Combine with Dendritic Cell-Based Immunotherapy to Suppress Tumor Growth in a Mouse Model of HER-2pos Disease

Crystal M. Oechsle, Loral E. Showalter, Colleen M. Novak et al. · Vaccines · 2020 · 19 citations · Full text

, , +17

TRPA1 and TRPV1 contribute to propofol-mediated antagonism of U46619-induced constriction in murine coronary arteries

Pritam Sinharoy, Ian N. Bratz, Sayantani Sinha et al. · PLoS ONE · 2017 · 18 citations · Full text

, , +17

Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells <i>in vitro</i> and suppress tumor growth <i>in vivo</i>

Loral E. Showalter, Brian J. Czerniecki, Gary K. Koski · Oncotarget · 2020 · 14 citations · Full text

, , +17

Calcium mobilizing treatment acts as a co-signal for TLR-mediated induction of Interleukin-12 (IL-12p70) secretion by murine bone marrow-derived dendritic cells

Emily Huang, Loral E. Showalter, Shuwen Xu et al. · Cellular Immunology · 2017 · 10 citations

, , +16

1–5 of 5